Acute lymphoblastic leukaemia - inotuzumab ozogamicin initial (induction) authority application form (PB269)

Use this form to apply for initial (induction) PBS-subsidised inotuzumab ozogamicin treatment for acute lymphoblastic leukaemia.

Page last updated: 1 June 2025.
QC 49941